Publication: Preparation and biocompatibility study of in situ forming polymer implants in rat brains
Issued Date
2012-02-01
Resource Type
ISSN
15734838
09574530
09574530
Other identifier(s)
2-s2.0-84863482050
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Materials Science: Materials in Medicine. Vol.23, No.2 (2012), 497-505
Suggested Citation
Norased Nasongkla, Atthaporn Boongird, Suradej Hongeng, Chawan Manaspon, Noppadol Larbcharoensub Preparation and biocompatibility study of in situ forming polymer implants in rat brains. Journal of Materials Science: Materials in Medicine. Vol.23, No.2 (2012), 497-505. doi:10.1007/s10856-011-4520-3 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/13808
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Preparation and biocompatibility study of in situ forming polymer implants in rat brains
Other Contributor(s)
Abstract
We describe the development of polymer implants that were designed to solidify once injected into rat brains. These implants comprised of glycofurol and copolymers of D,Llactide (LA), ε-caprolactone and poly(ethylene glycol) (PLECs). Scanning electron microscopy (SEM) and gel permeation chromatography (GPC) showed that the extent of implant degradation was increased with LA content in copolymers. SEM analysis revealed the formation of porosity on implant surface as the degradation proceeds. PLEC with 19.3% mole of LA was chosen to inject in rat brains at the volume of 10, 25 and 40 ll. Body weights, hematological and histopathological data of rats treated with implants were evaluated on day 3, 6, 14, 30 and 45 after the injection. Polymer solution at the injection volume of 10 ll were tolerated relatively well compared to those of 25 and 40 ll as confirmed by higher body weight and healing action (fibrosis tissue) 30 days after treatment. The results from this study suggest a possible application as drug delivery systems that can bypass the blood brain barrier. © 2011 Springer Science+Business Media, LLC.
